On 2025-05-12, Apogee Therapeutics Inc. (APGE) announced earnings per share of $-0.95 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.19.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-1.08 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-1.19 | $-0.95 |
| 2025-03-03 | 2024-12-31 | $-0.94 | $-1.19 |
| 2024-11-12 | 2024-09-30 | $-0.73 | $-0.86 |
| 2024-08-12 | 2024-06-30 | $-0.64 | $-0.60 |
| 2024-05-13 | 2024-03-31 | $-0.60 | $-0.64 |
| 2024-03-05 | 2023-12-31 | $-0.45 | $-0.32 |
| 2023-11-13 | 2023-09-30 | $-0.38 | $-0.51 |
| 2023-08-28 | 2023-06-30 | $-0.47 | $-3.78 |